These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1643200)

  • 1. Effects of platelets and plasma on fibrinolysis.
    Lefebvre P; Cohen I
    Blood Coagul Fibrinolysis; 1992 Jun; 3(3):237-41. PubMed ID: 1643200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of platelet PAl-1 in t-PA mediated clot lysis of platelet rich plasma.
    Serizawa K; Urano T; Kozima Y; Takada Y; Takada A
    Thromb Res; 1993 Aug; 71(4):289-300. PubMed ID: 8236158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing effect of platelets on staphylokinase-mediated clot lysis and plasminogen activation.
    Suehiro A; Tsujioka H; Yoshimoto H; Ueda M; Higasa S; Kakishita E
    Thromb Res; 1995 Oct; 80(2):135-42. PubMed ID: 8588190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
    Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
    Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
    Torr-Brown SR; Sobel BE
    Thromb Res; 1993 Dec; 72(5):413-21. PubMed ID: 8303684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time measurement of lysis of mural platelet deposits by fibrinolytic agents under arterial flow.
    Graham DA; Huang TC; Keyt BA; Alevriadou BR
    Ann Biomed Eng; 1998; 26(4):712-24. PubMed ID: 9662163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
    Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M
    Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia.
    Pósán E; Ujj G; Kiss A; Telek B; Rák K; Udvardy M
    Thromb Res; 1998 Apr; 90(2):51-6. PubMed ID: 9684757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of platelets and leukocytes in coagulation and fibrinolysis.
    Cucuianu M; Trif I
    Rev Roum Physiol (1990); 1992; 29(1-2):33-8. PubMed ID: 1472550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin effect on the release of plasminogen activator inhibitors by human platelets.
    Woods AI; Lazzari MA
    Thromb Res; 1988 Oct; 52(2):119-25. PubMed ID: 3143164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets.
    Widmer K; Moake JL; Kent CJ; Yeo YY; Reynolds JP
    J Lab Clin Med; 1976 Jan; 87(1):49-57. PubMed ID: 1245783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage.
    Moore HB; Moore EE; Gonzalez E; Wiener G; Chapman MP; Dzieciatkowska M; Sauaia A; Banerjee A; Hansen KC; Silliman C
    J Am Coll Surg; 2015 May; 220(5):872-9. PubMed ID: 25840538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
    Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
    Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estriol-induced fibrinolysis due to the activation of plasminogen to plasmin by nitric oxide synthesis in platelets.
    Jana P; Maiti S; Kahn NN; Sinha AK
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):316-23. PubMed ID: 24695088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
    Loza JP; Gurewich V; Johnstone M; Pannell R
    Thromb Haemost; 1994 Mar; 71(3):347-52. PubMed ID: 8029800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of staphylokinase with human platelets.
    Lijnen HR; Van Hoef B; Collen D
    Thromb Haemost; 1995 Mar; 73(3):472-7. PubMed ID: 7667831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of exogenous carbon monoxide-releasing molecules 2 on endotoxin/lipopolysaccharide-induced abnormal activation of platelets of healthy human donors].
    Liu D; Zhuang M; Zhang J; Chen J; Sun B
    Zhonghua Shao Shang Za Zhi; 2015 Oct; 31(5):354-60. PubMed ID: 26714404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis.
    Collet JP; Montalescot G; Lesty C; Soria J; Mishal Z; Thomas D; Soria C
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):142-8. PubMed ID: 11145946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity.
    Gurewich V; Pannell R
    Thromb Res; 1986 Oct; 44(2):217-28. PubMed ID: 3097872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
    Robbie LA; Booth NA; Croll AM; Bennett B
    Thromb Haemost; 1993 Aug; 70(2):301-6. PubMed ID: 8236139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.